Finally, survival analysis of CX3CL1 in ccRCC was performed in terms of OS (P <  0.001), DSS (P <  0.001), PFS (P <  0.001), and DFS (P = 0.694) (Fig. 2I–L). This evidence concerns the gene CX3CL1 and nonpapillary renal cell carcinoma.